Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

245.65
BATS BZX Real-Time Price
As of 10:12am ET
 -1.46 / -0.59%
Today’s Change
184.50
Today|||52-Week Range
261.27
+16.97%
Year-to-Date
My Trading and Investing Activity in Thursday's Session
8:06am / TheStreet.com - Paid Partner Content
The Market Advance Narrows
Jun 22 / TheStreet.com - Paid Partner Content
The Long and Short of It
Jun 22 / TheStreet.com - Paid Partner Content
FDA Commisoner Takes on Big Pharma
Jun 21 / TheStreet.com - Paid Partner Content
Getting Ever Smaller in Allergan
Jun 22 / TheStreet.com - Paid Partner Content
Time Frames and Market Views -- Selling Some Allergan
Jun 20 / TheStreet.com - Paid Partner Content
Putting More Allergan Profit in My Pocket
Jun 22 / TheStreet.com - Paid Partner Content
5 Reasons Why You Should Invest in AstraZeneca (AZN) in 2017
Jun 20 / Zacks.com - Paid Partner Content
Pocketing Some Allergan Profit
Jun 22 / TheStreet.com - Paid Partner Content
Still Lovin' Allergan
Jun 20 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close247.11
Today’s open247.27
Day’s range245.09 - 247.48
Volume15,971
Average volume (3 months)2,545,724
Market cap$83.0B
Dividend yield1.14%
Data as of 10:12am ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+281.42%
Earnings growth (this year)+19.00%
Earnings growth (next 5 years)+13.70%
Revenue growth (last year)-3.32%
P/E ratioNM
Price/Sales5.55
Price/Book1.16

Competitors

 Today’s
change
Today’s
% change
NVONovo Nordisk+0.34+0.78%
ABTAbbott Laboratories-0.12-0.24%
AZNAstraZeneca-0.17-0.48%
LLYEli Lilly and Co-0.39-0.46%
Data as of 10:13am ET, 06/23/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)$3.94
Annual revenue (last year)$14.6B
Annual profit (last year)$15.0B
Net profit margin-6.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chairman, President &
Chief Executive Officer
Brenton L. Saunders
Chief Operating Officer
Robert A. Stewart
Corporate headquarters
Dublin, Dublin

Forecasts